FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073504 [Registered on: 06/09/2024] Trial Registered Prospectively
Last Modified On: 03/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Probiotic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing Oral Metronidazole VS Oral Metronidazole with Oral Probiotics in the treatment of Bacterial vaginosis 
Scientific Title of Study   A Comparative study on the efficacy of Oral Metronidazole VS Oral Metronidazole with ORAL Probiotics in the management of Bacterial Vaginosis  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Soundharya G 
Designation  Post Graduate  
Affiliation  Government Stanley Medical College 
Address  Government Stanley Medical College , SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, Chennai

Chennai
TAMIL NADU
600001
India 
Phone  8220332489  
Fax    
Email  soundhak99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Jayanthi N S 
Designation  Associate Professor 
Affiliation  Government Stanley Medical College 
Address  Government Stanley Medical College , SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, CHENNAI

Chennai
TAMIL NADU
600001
India 
Phone  9600694059  
Fax    
Email  jay11079@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Soundharya G 
Designation  Post Graduate 
Affiliation  Government Stanley Medical College 
Address  Government Stanley Medical College , SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, Chennai

Chennai
TAMIL NADU
600001
India 
Phone  8220332489  
Fax    
Email  soundhak99@gmail.com  
 
Source of Monetary or Material Support  
Government Stanley Medical College , SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, Chennai 600001 
 
Primary Sponsor  
Name  Soundharya G 
Address  Government Stanley Medical College , SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, Chennai 600001 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Soundharya G  Government Stanley Medical College  SSB 1ST Floor , Department of DVL 1 , Old Jail Road, George town, Chennai 600001
Chennai
TAMIL NADU 
8220332489

soundhak99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government Stanley Medical College and Hospital, Chennai -01, Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N00-N99||Diseases of the genitourinary system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  oral metronidazole   Oral Metronidazole 400 mg BD daily for 1 week  
Comparator Agent  oral metronidazole with oral probiotics  Oral Metronidazole 400mg BD daily for 1 week plus oral lactobacillus(containing Lactobacillus rhamnosus and Lactobacillus reuteri each 1 million colony forming units ) given twice daily for 4weeks, followed by once daily for next 4 weeks (total – 2months) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Patient with more than 18 years of age


Patient with complaints of vaginal discharge satisfying Amsel criteria

Patient willing for consent, study and regular follow up

Patient willing to take photograph
 
 
ExclusionCriteria 
Details  Patients below 18 years.

Patients with sexually transmitted diseases such as HIV , Syphilis, Hepatitis B and Hepatitis C

Patient with vaginal discharge due to co-existing genital ulcer

Patient with other infective causes of vaginal discharge such as Trichomonas vaginitis, vulvovaginal candidiasis

Patients who are on treatment with any antibiotics 6 weeks prior to the study

Lactating or Pregnant women

 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
clinical and microbiological cure  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
decreases the recurrences  1 year 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   17/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

It is a Randomized Control Study. Patients satisfying the inclusion criteria will be included in the study. Patient socio demographic data and a thorough history will be taken. General examination, systemic examination, Genital examination under Cusco’s bivalve self-retaining vaginal speculum will be done. Genital discharge smears will be taken from the posterior fourchette and Vaginal discharge will be subjected for sniff test, whiff test, vaginal pH examination using litmus papers. Vaginal discharge will be investigated under saline mount, KOH examination, Gram staining of vaginal smear. After diagnosis of Bacterial vaginosis using Amsel’s criteria patients are randomized into two groups A and B ( randomization by Simple random sampling )

Group A:

 Patients in this group will receive Oral Metronidazole 400 mg BD daily for 1 week

Group B:

Patients in this group will receive Oral Metronidazole 400mg BD  daily for 1 week plus oral lactobacillus(containing Lactobacillus rhamnosus and Lactobacillus reuteri each 1 million colony forming units ) given twice daily for 4weeks, followed by once daily for next 4 weeks (total â€“ 2months)

 


 
Close